Three-drug pill reduced blood pressure swings after brain bleed
The spread of upper blood pressure readings, measured by standard deviation, was 2.05 mmHg lower with the pill than with placebo.
Double-blind, placebo-controlled, multicenter
Limit: Lower average pressure largely explained reduced swings; the mean-adjusted variability measure did not change
Edited by Boris Djordjevic · AgingResearch.News
The randomized, placebo-controlled TRIDENT trial studied 1,670 people with prior bleeding within the brain and systolic blood pressure—the upper reading—of 130–160 mmHg. All completed a two-week active-drug run-in before randomization. This analysis included 1,557 participants with more than one follow-up reading; their mean age was 58, and 33% were female.
Participants received usual care plus placebo or a pill containing telmisartan 20 mg, amlodipine 2.5 mg and indapamide 1.25 mg. Mean follow-up was three years. The combination reduced three measures of variability in both upper and lower pressure readings. It did not change a measure that accounts for average pressure. The authors concluded that the variability reductions were predominantly attributable to lower average blood pressure.
Why it matters
Blood pressure variability predicts cardiovascular events and stroke independently of average pressure. This analysis addressed whether the pill affected that risk-related pattern beyond lowering average readings.
Caveats
The analysis included only participants with repeated follow-up readings who had prior brain hemorrhage and completed an active-drug run-in. The congress abstract did not report adverse events or establish effects in people without prior brain hemorrhage.
The paper
The George Institute for Global Health
ESC Congress 2026 Abstract, Oct 26, 2026, Open access
Presented at ESC Congress 2026
